The FDA is under scrutiny after a troubling baby formula recall and reports of two infant fatalities. Mistakes made by both the FDA and the formula manufacturer appear to have contributed to these tragic outcomes.
On February 17, baby formula producer Abbot announced a widespread recall of various powdered infant formulas from its Sturgis, Michigan facility. This action came in response to FDA inspections that uncovered evidence of five strains of Cronobacter, a harmful bacteria linked to four hospitalizations and two infant deaths related to the formula produced at the site. In light of these events, consumer advocates and health experts are questioning the FDA’s inspection procedures and the policies that may have played a role in this crisis, particularly during the pandemic.
A recent investigation by Politico revealed a concerning timeline: the first report of an infant becoming ill occurred back in September 2021, coinciding with the FDA’s first inspection of the plant since 2019. While this initial inspection identified minor violations, there was no sign of bacterial contamination in the infant formulas, raising concerns about the thoroughness of the inspection. By the time the FDA conducted another inspection in late January, two babies had already died. Questions arise about the four-month gap between inspections, especially given the reports of illness, and why the facility had gone two years without an inspection, when such plants typically undergo annual reviews.
The skipped 2020 inspection can likely be attributed to the FDA’s decision to limit inspections to those deemed “mission critical” during the peak of the pandemic. However, it is perplexing why a plant that produces infant formula—a critical source of nutrition for vulnerable infants—was not classified as ‘critical.’ According to agency representatives, decisions were made on a case-by-case basis.
Recent findings from the FDA’s latest inspection were alarming, revealing that Abbot had detected Cronobacter during its own internal inspections in September 2019 and June 2020. The company reportedly destroyed the contaminated products, but it remains unclear whether FDA inspectors were informed about the initial case of Cronobacter during their September visit, which could have affected their assessment.
Sara Conner, a regulatory affairs expert at the Center for Food Safety Oversight, stated, “The recent inspection highlighted numerous issues that were overlooked during the previous evaluation. It raises significant questions about what else may have been missed.” An FDA spokesperson indicated that the agency plans to review the situation “once the immediate public health risk is mitigated.”
Microbiologist Tara Ellis, who operates eFoodAlert, emphasized that both the manufacturer and the FDA share responsibility for the failures. “Ultimately, it’s the company’s job to ensure their equipment and safety measures are up to par. The FDA’s role is to oversee and ensure compliance,” she noted. “It’s evident that there were failures on multiple fronts.”
It is crucial that these investigations prompt the FDA, Abbot, and other infant formula manufacturers to enhance their protocols to prevent future contamination cases, as children’s lives depend on it. To check if your purchased formula is part of the recall, you can visit this link.
For additional insights related to home insemination, check out this informative blog post. If you’re looking for expert resources on pregnancy, the National Institutes of Health provides an excellent overview.
Search Queries
- home insemination kit
- home insemination syringe
- self insemination
- baby formula recall news
- FDA inspection process
In summary, the FDA is facing significant backlash due to its role in the baby formula recall and the tragic deaths of infants. The investigation reveals gaps in inspection protocols and raises critical questions about the safety measures in place to protect vulnerable populations.
Leave a Reply